Stock Price
29.51
Daily Change
4.67 18.78%
Monthly
11.05%
Yearly
41.85%
Q1 Forecast
22.31

Celldex Therapeutics reported $66.45M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agenus USD 266K 30K Mar/2025
Amgen USD 539M 1000K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celldex Therapeutics USD 66.45M 53K Sep/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Northwest Biotherapeutics USD 1.14M 30K Sep/2023
Pfizer USD 5.69B 1000K Sep/2025
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Roche Holding CHF 795.62M 699.54K Dec/2025